Plutus1813

[TimChallenge] kinda seems similar/parallel in a sense with the Epi-pen stocks, $MYL is king, and kaboshed $ADMP, though $ADMP could still release news, but it will apparently take months before the FDA will even look/review their product again, since testing, and resubmitting takes as long...at least that is what I have heard...so in regards to $ADMP, I think that stock stays in its range of mid to high 2's with little volume...

Page
of 23